Company Spotlight / Iberma
Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding in 1994 to become the market leader in several therapeutic areas. The company also…
After implementing the most successful COVID-19 inoculation campaign on the African continent, Morocco is looking to bolster its biologics and vaccine manufacturing capacity via two major agreements with Swedish CDMO Recipharm and Chinese Sinopharm. The North African nation hopes to…
Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding in 1994 to become the market leader in several therapeutic areas. The company also…
Morocco has made admirable progress in building a national oncology network in recent years, but the country’s cancer patients still face significant challenges in terms of accessing the latest therapies.…
Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year double-digit growth for the affiliate ever since. His current priorities include…
Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation, its therapeutic priorities, and the opportunities that exist for women in leadership in Morocco. Today, we are the only laboratory in Morocco exclusively dedicated to women’s and children’s well-being, supporting women through the different stages of their life and helping…
After implementing the most successful COVID-19 inoculation campaign on the African continent, Morocco is looking to bolster its biologics and vaccine manufacturing capacity via two major agreements with Swedish CDMO…
After implementing the most successful COVID-19 inoculation campaign on the African continent, Morocco is looking to bolster its biologics and vaccine manufacturing capacity via two major agreements with Swedish CDMO…
See our Cookie Privacy Policy Here